Talphera (TLPH) Research & Development (2010 - 2026)

Talphera's (TLPH) quarterly Research & Development came in at $1.6 million in Q1 2026, up 41.15% year-on-year from $1.2 million in Q1 2025, and up 5.7% quarter-over-quarter from $1.6 million in Q4 2025.

Talphera (TLPH) Research & Development (2010 - 2026) Analysis & Trends

Talphera's Research & Development history runs 17 years deep, the most recent figure standing at $1.6 million for Q1 2026.

  • On a quarterly basis, Research & Development rose 41.15% year-over-year to $1.6 million in Q1 2026; TTM through Mar 2026 was $6.5 million, a 0.93% increase from a year earlier, with the FY2025 full-year figure at $6.0 million, down 10.2% from the prior year.
  • Research & Development rose to $1.6 million in Q1 2026 per TLPH's latest filing, from $1.6 million in the prior quarter.
  • Across five years, Research & Development topped out at $2.1 million in Q3 2024 and bottomed at $612000.0 in Q4 2022.
  • The 5-year median for Research & Development is $1.5 million (2024), against an average of $1.4 million.
  • Across the five-year window, Research & Development tumbled 43.57% in 2022 and jumped 189.05% in 2023, its largest moves.
  • Year by year, Research & Development stood at $612000.0 in 2022, then soared by 189.05% to $1.8 million in 2023, then dropped by 25.21% to $1.3 million in 2024, then rose by 17.99% to $1.6 million in 2025, then advanced by 5.7% to $1.6 million in 2026.
  • Per Business Quant, the three latest TLPH Research & Development figures stand at $1.6 million (Q1 2026), $1.6 million (Q4 2025), and $1.8 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Haleon 88.07 Bn 86.20 Bn - -
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn 696.00 Mn
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn 180.00 Mn
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn 7.37 Bn
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn 138.20 Mn
6 RedHill Biopharma 21.32 Bn 21.32 Bn - -
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn 248.60 Mn
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn 296.20 Mn
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn 97.00 Mn
10 Talphera 94.61 Mn 56.78 Mn - 1.65 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.65 Mn
Dec 31, 2025 1.56 Mn
Sep 30, 2025 1.80 Mn
Jun 30, 2025 1.50 Mn
Mar 31, 2025 1.17 Mn
Dec 31, 2024 1.32 Mn
Sep 30, 2024 2.05 Mn
Jun 30, 2024 1.91 Mn
Mar 31, 2024 1.43 Mn
Dec 31, 2023 1.77 Mn
Sep 30, 2023 1.18 Mn
Jun 30, 2023 1.55 Mn
Dec 31, 2022 612,000.00
Sep 30, 2022 799,000.00
Jun 30, 2022 1.09 Mn
Mar 31, 2022 1.32 Mn
Dec 31, 2021 986,000.00
Sep 30, 2021 1.42 Mn
Jun 30, 2021 724,000.00
Mar 31, 2021 969,000.00